Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies

Clinical and Experimental Rheumatology

Volumn 14, Issue 2, 1996, Pages 155-162

  Schlaak, J F ^a   Pfers, I ^a   Meyer Zum Buschenfelde K H ^a   Marker Hermann E ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

immunoregulatory cytokines; rheumatoid arthritis; seronegative spondylarthropathies; Th1 Th2 cytokines

Indexed keywords

AZATHIOPRINE; CYTOKINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIAL FLUID;

AGED; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; MONOKINES; OSTEOARTHRITIS; SPINAL DISEASES; SYNOVIAL FLUID; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029895089     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. REMICK DG, DEFORCE LE, SULLIVAN JF, SHOWELL HJ: Profile of cytokines in synovial fluid specimens from patients with arthritis. Interleukin 8 (IL-8) and IL-6 correlate with inflammatory arthritides. Immunol Invest 1992; 21: 321-7.
2. WAAGE A, KAUFMANN C, ESPEVIK T, HUSBY G: Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989; 50: 394-8.
3. XU WD, FIRESTEIN GS, TAETLE R, KAUSHANSKY K, ZVAIFLER NJ: Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989; 83: 876-82.
4. PEICHL P, CESKA M, EFFENBERGER F, HABERHAUER G, BROELL H, LINDLEY IJ: Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991; 34: 333-9.
5. ROUX LOMBARD P, PUNZI L, HASLER F, BAS S, TODESCO S, GALLATI H, GUERNE PA, DAYER JM: Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993; 36: 485-9.
6. HENDERSON B, THOMPSON RC, HARDINGHAM T, LEWTHWAITE J: Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 1991; 3: 246-9.
7. PANAYI GS, LANCHBURY JS, KINGSLEY GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis [editorial]. Arthritis Rheum 1992; 35: 729-35.
8. DIAMANTSTEIN T, ECKERT R, VOLK HD, KUPER WEGLINSKI JW: Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anti-CD4 or anti-interleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role ofthe CD4+ TH1+ subset in mice. Eur J Immunol 1988; 18: 2101-3.
9. BOOM WH, LIANO D, ABBAS AK: Heterogeneity of helper/ inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J Exp Med 1988; 167: 1350-63.
10. SCHLAAK JF, HERMANN E, RINGHOFFER M, PROBST P, GALLATI H, MEYER ZUM BÜSCHENFELDE KH, FLEISCHER B: Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur J Immunol 1992; 22: 2771-6.
11. SCHLAAK JF, BUSLAU M, JOCHUM W, HERMANN E, GIRNDT M, GALLATI H, MEYER ZUM BUSCHENFELDE KH, FLEISCHER B: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
12. HAANEN JBAG, DE WAAL MALEFIJT R, RES PCM, KRAAKMAN EM, OTTENHOFF THM, DE VRIES RRP, SPITS H: Selection of a human T helper type 1 -like T cell subset by mycobacteria. J Exp Med 1991; 174: 583-92.
13. YSSEL H, SHANAFELT M-C, SODERBERG C, SCHNEIDER PV, ANZOLA J, PELTZ G: Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991; 174: 593-601.
14. WIERENGA EA, SNOEK M, JANSEN HM, BOS JD, VAN LER RA, KAPSENBERG ML: Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991; 147: 2942-9.
15. MOORE KW, VIEIRA P, FIORENTINO DF, TROUNSTINE ML, KHAN TA, MOSMANN TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-4.
16. O'GARRA A, STAPLETON G, DHAR V, PEARCE M, SCHUMACHER J, RUGO H, BARBIS D, STALL A, CUPP J, MOORE K, et al.: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2: 821-32.
17. HEINZEL FP, SADICK MD, MUTHA SS, LOCKSLEY RM: Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991; 88: 7011-5.
18. FIORENTINO DF, ZLOTNIK A, MOSMANN TR, HOWARD M, O'GARRA A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
19. ENK AH, KATZ SI: Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 148: 92-5.
20. DING L, SHEVACH EM: IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148: 3133-9.
21. DE WAAL MALEFYT R, HAANEN J, SPITS H, RONCAROLO MG, TE VELDE A, FIGDOR C, JOHNSON K, KASTELEIN R, YSSEL H, DE VRIES JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-24.
22. ROUSSET F, GARCIA E, DEFRANCE T, PERONNE C, VEZZIO N, HSU DH, KASTELEIN R, MOORE KW, BANCHEREAU J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-3.
23. MENGEL J, DARE L, DARE GM, DELGADO M, NOMIZO A, SILVA JS, CAMPOS NETO A: An activated murine B cell lymphoma line (A-20) produces a factor-like activity which is functionally related to human natural killer cell stimulatory factor. Eur J Immunol 1992; 22: 3173-8.
24. TRINCHIERI G, RENGARAJU M, D'ANDREA A, VALIANTE NM, KUBIN M, ASTE M, CHEHIMI J: Producer cells of interleukin- 12 [letter]. Immunol Today 1993; 14: 237-8.
25. WU CY, DEMEURE C, KINIWA M, GATELY M, DELESPESSE G: IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 1993; 151: 1938-49.
26. MANETTI R, PARRONCHI P, GIUDIZI MG, PICCINI M, MAGGI E, TRINCHIERI G, ROMAGNANI S: Natural killer cell stimulatory factor (Interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199-204.
27. SIMON AK, SEIPELT E, SEPER J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91: 8562-6.
28. KATSIKIS PD, CHU CQ, BRENNAN FM, MAINI RN, FELDMANN M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-27.
29. FARGEAS C, WU CY, NAKAJIMA T, COX D, NUTMAN T, DELESPESSE G: Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur J Immunol 1992; 22: 2173-6.
30. CUSH JJ, SPLAWSKI JB, THOMAS R, MCFARLIN JE, SCHULZE-KOOPS H, DAVIES LS, FUJITA K, LIPSKY PE: Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
31. VAN DER POUW-KRAAN T, DE JONG R, AARDEN L: Development of human Th1 and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur J Immunol 1993; 23: 1-5.
32. MAGGI E, PARRONCHI P, MANETTI R, SIMONELLI C, PICCINNI MP, RUGIU FS, DE CARLI M, RICCI M, ROMAGNANI S: Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148: 2142-7.
33. HSEH CS, HEIMBERGER AB, GOLD JS, O'GARRA A, MURPHY KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992; 89: 6065-9.